Treatment satisfaction and quality of life in patients treated with fingolimod.

about

Treatment satisfaction and quality of life in patients treated with fingolimod.

Item

http://www.wikidata.org/entity/Q55314123

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Treatment satisfaction and quality of life in patients treated with fingolimod.

@en

Treatment satisfaction and quality of life in patients treated with fingolimod.

@nl

type

Item

label

Treatment satisfaction and quality of life in patients treated with fingolimod.

@en

Treatment satisfaction and quality of life in patients treated with fingolimod.

@nl

prefLabel

Treatment satisfaction and quality of life in patients treated with fingolimod.

@en

Treatment satisfaction and quality of life in patients treated with fingolimod.

@nl

P1476

Treatment satisfaction and quality of life in patients treated with fingolimod

@en

P2093

Anne-Laure Ramelli

http://www.w3.org/2001/XMLSchema#string

Béatrice Jenny

http://www.w3.org/2001/XMLSchema#string

Claude Mékiès

http://www.w3.org/2001/XMLSchema#string

Olivier Heinzlef

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

Multiple sclerosis

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform

EuroQol--a new facility for the measurement of health-related quality of life

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.

Treatment satisfaction in multiple sclerosis.

Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis

P304

899-907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PPA.S144021

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P Clavelou

P577

2018-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29872275

http://www.w3.org/2001/XMLSchema#string

P932

5973401

http://www.w3.org/2001/XMLSchema#string